News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
440 Results
Type
Article (78)
Company Profile (1)
Press Release (361)
Section
Business (116)
Career Advice (2)
Deals (33)
Drug Delivery (1)
Drug Development (110)
FDA (18)
Job Trends (2)
News (246)
Policy (17)
Tag
Allergies (1)
Alliances (20)
Alzheimer's disease (3)
Approvals (16)
Bladder cancer (1)
Brain cancer (1)
Breast cancer (1)
Cancer (4)
Cardiovascular disease (2)
Career advice (2)
CAR-T (3)
Cell therapy (7)
Clinical research (85)
Compensation (15)
Complete response letters (1)
C-suite (2)
Data (9)
Diagnostics (2)
Drug discovery (1)
Earnings (52)
Events (67)
Executive appointments (5)
FDA (20)
Funding (1)
Gene therapy (1)
GLP-1 (19)
Government (1)
Healthcare (3)
Immunology and inflammation (2)
IPO (15)
Job creations (1)
Job search strategy (2)
JPM (1)
Layoffs (2)
Lung cancer (1)
Manufacturing (2)
MASH (37)
Medical device (1)
Medtech (1)
Mergers & acquisitions (21)
Metabolic disorders (39)
NASH (13)
Neurodegenerative disease (1)
Neuroscience (4)
Non-profit (1)
Obesity (5)
Opinion (3)
Pain (1)
Patents (1)
People (49)
Pharmaceutical (1)
Phase 1 (7)
Phase 2 (41)
Phase 3 (49)
Pipeline (8)
Policy (1)
Postmarket research (3)
Preclinical (4)
Psychedelics (2)
Rare diseases (3)
Real estate (2)
Regulatory (23)
Schizophrenia (2)
Startups (1)
The Weekly (4)
Vaccines (1)
Venture capital (1)
Weight loss (3)
Date
Last 7 days (2)
Last 30 days (6)
Last 365 days (66)
2026 (6)
2025 (67)
2024 (69)
2023 (44)
2022 (31)
2021 (19)
2020 (20)
2019 (20)
2018 (29)
2017 (28)
2016 (18)
2015 (17)
2014 (9)
2013 (11)
2012 (10)
2011 (13)
2010 (10)
Location
Asia (10)
Australia (1)
California (4)
Delaware (1)
Europe (36)
Louisiana (1)
Maryland (1)
Massachusetts (1)
Northern California (2)
Pennsylvania (92)
Southern California (1)
United States (101)
Virginia (1)
440 Results for "madrigal pharmaceuticals.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2025 Financial Results and Host Webcast on February 19, 2026
February 2, 2026
·
1 min read
MASH
Madrigal Makes Potential $2B+ Bet for CSPC’s GLP-1 Pill
Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for clinical trials in early 2026.
July 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026
February 6, 2026
·
1 min read
Press Releases
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - January 22, 2026
January 23, 2026
·
1 min read
Press Releases
Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4) - January 21, 2026
January 22, 2026
·
1 min read
Press Releases
Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
·
1 min read
Press Releases
Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor
January 9, 2026
·
11 min read
Press Releases
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - November 17, 2025
November 18, 2025
·
1 min read
Press Releases
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - December 18, 2025
December 19, 2025
·
1 min read
Press Releases
Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates
November 5, 2025
·
11 min read
1 of 44
Next
